logo

High Content Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The High Content Screening Market is segmented by Type of Product (Instruments, Consumables, Software, and Other Products), Application, End User, and Geography.

Home Industry Reports Healthcare High Content Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts ( ...

Market Snapshot

High Content Screening Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.74 %
High Content Screening Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Under the conventional method of toxicity studies, large libraries are screened in search of potential drug candidates. This method is expensive, resource- and time-consuming, and has a low success rate. Consequently, high content screening (HCS) solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in-vitro toxicity testing by reducing the time and cost.

  • The need for cost containment in pharmaceutical R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market.
  • The increasing number of contract research organizations providing HCS outsourcing services and the application of HCS in personalized medicine present significant growth opportunities in the market.

Scope of the Report

High content screening (HCS) is a method that is used in biological research and drug discovery to identify substances, such as small molecules, peptides, or RNAi, that alter the phenotype of a cell in the desired manner. High content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.

By Product
Instruments
Cell Imaging and Analysis Systems
Flow Cytometers
Consumables
Reagents and Assay Kits
Microplates
Other Consumables
Software
Other Products
By Application
Primary and Secondary Screening
Target Identification and Validation
Toxicity Studies
Compound Profiling
Other Applications
By End User
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organization
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Instrument Segment is Expected to Lead the Market Over the Forecast Period

Based on the product segment, the high content screening market is further segmented into instruments, consumables, and software and services. Among all high content screening products, the instrument segment occupies the largest share of the market. The large share of this segment is attributed to advances in instrumentation and automation techniques and the high prices of HCS instruments. Companies are developing automated solutions such as instruments with advanced visualization capability, in line with the enhanced software platform. These advances are boosting the market growth. In January 2017, PerkinElmer Inc. launched the Vectra Polaris automated quantitative pathology imaging system. This multi-modal tissue imaging system enables researchers to gain a deeper level of understanding of disease mechanisms related to new cancer immunotherapy approaches. The increasing funds for product development and increasing use of the instruments are boosting the segment.

High Content Screening Market Trends

Asia-Pacific Region is Expected to Attain the Highest Growth Rate Over the Forecast Period

The high content screening market in Asia-Pacific is expected to register the highest CAGR over the forecast period. Factors, such as increasing drug discovery research, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure, are driving the growth of the HCS market in this region. Japan and China are expected to witness significant growth during the forecast period, as many research and development programs are carried out by manufacturers to improve the cell analyzers and flow cytometers in the high content screening market.

High Content Screening Market Analysis

Competitive Landscape

For compound profiling applications, many pharmaceutical companies are partnering with contract research organizations to identify potential candidates for drug discovery. The HCS market is highly competitive in nature. The majority of large global players are based out of the United States, and these players have expertise in other biotechnology/medical-technology verticals as well, which helps them in controlling the major market share, through a presence in the allied markets.

Becton, Dickinson and Company, Perkinelmer Inc., Danaher Corporation, Thermo Fisher Scientific Inc., GE Healthcare

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Government Funding and Venture Capital Investments Across Developed Markets​

      2. 4.2.2 Increasing Applications of HCS in Life Science Research​

      3. 4.2.3 Advancements in Informatic Solutions and Imaging Systems​

    3. 4.3 Market Restraints

      1. 4.3.1 Lower Adoption of HCS Instruments Due to Their High Prices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Instruments

        1. 5.1.1.1 Cell Imaging and Analysis Systems

        2. 5.1.1.2 Flow Cytometers

      2. 5.1.2 Consumables

        1. 5.1.2.1 Reagents and Assay Kits

        2. 5.1.2.2 Microplates

        3. 5.1.2.3 Other Consumables

      3. 5.1.3 Software

      4. 5.1.4 Other Products

    2. 5.2 By Application

      1. 5.2.1 Primary and Secondary Screening

      2. 5.2.2 Target Identification and Validation

      3. 5.2.3 Toxicity Studies

      4. 5.2.4 Compound Profiling

      5. 5.2.5 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Academic and Government Institutions

      3. 5.3.3 Contract Research Organization

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 GE Healthcare

      2. 6.1.2 Danaher Corporation

      3. 6.1.3 Perkinelmer Inc.

      4. 6.1.4 Thermo Fisher Scientific Inc.

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Biotek Instruments Inc.

      7. 6.1.7 Bio-Rad Laboratories Inc.

      8. 6.1.8 Yokogawa Electric Corporation

      9. 6.1.9 Merck KGaA

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The High Content Screening Market market is studied from 2018 - 2026.

The High Content Screening Market is growing at a CAGR of 8.74% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Becton, Dickinson and Company, Perkinelmer Inc., Danaher Corporation, Thermo Fisher Scientific Inc., GE Healthcare are the major companies operating in High Content Screening Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!